Product
18F Fluciclovine
Aliases
18F fluciclovine, Axumin
Name
Axumin
FDA Approved
Yes
2 clinical trials
1 organization
1 drug
1 indication
1 document
Indication
Brain MetastasesClinical trial
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation TherapyStatus: Completed, Estimated PCD: 2023-06-05
Clinical trial
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation TherapyStatus: Completed, Estimated PCD: 2021-12-31
Document
DailyMed Label: AxuminOrganization
Blue Earth Diagnostics